| Name rehabs | Address | Phone |
|---|---|---|
| Hazelden Foundation | 15251 Pleasant Valley Road Center City, MN 55012 | (800) 257-7800 |
Rules and regulations: Center City, Chisago County, Minnesota, United States adheres to strict federal and state regulations regarding methadone clinics, outlined by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Minnesota Board of Pharmacy.
Certification Procedures:
- Methadone clinics must register with SAMHSA and acquire a certification showing they comply with opioid treatment standards.
- Staff must undergo thorough background checks and training.
- Facilities must meet security, counseling, and dosing requirements.
Medication-assisted treatment with methadone helps individuals with opioid use disorder by:
- Preventing painful withdrawal symptoms
- Reducing opioid cravings
- Allowing people to regain stability and improve their health and behavior
How Clinics Operate and Their Purpose:
- Methadone clinics provide monitored, controlled doses of methadone to treat opioid dependence. The medication blocks the effects of opioids and reduces cravings and withdrawal symptoms. In conjunction with counseling, clinics help patients work toward recovery goals and live healthier, more stable lives.
Insurance Coverage
- Most private insurance and Medicaid cover methadone treatment.
- Some clinics also offer treatment on a sliding fee scale based on income for those without coverage. Grants, state and federal funding may also offset treatment costs at certain non-profit or public clinics. Patients should check with their insurance provider and clinic to understand their coverage and potential out-of-pocket costs.
Drug Use in Center City
Opioid crisis declared public health emergency
- In 2017, the opioid epidemic was declared a nationwide public health emergency in the United States.
Statistics on drug overdoses and deaths
- In Minnesota in 2020 there were 1,279 drug overdose deaths, a 35% increase from 2019. Over 75% of those deaths involved opioids.
- Synthetic opioids like fentanyl are increasingly involved in overdose deaths across Minnesota.
Addiction Treatment Overview
Inpatient Treatment
- Patients reside at the treatment facility for the duration of the program, typically 30-90 days. Treatment utilizes counseling, behavioral therapy, medication-assisted treatment, and peer support.
Outpatient Treatment
- Patients attend structured programming at a facility for 10-12 hours a week while continuing to live at home. Outpatient treatment typically lasts 90 days.
Comparison of Treatment in Center City vs. Neighboring Major City
City | Treatment Centers | Inpatient Beds | Cost of Treatment |
Center City | 2 | 50 | $10,000/month |
Minneapolis | 12 | 200 | $15,000/month |
Methadone Treatment
What is Methadone
- Methadone is a long-acting opioid agonist medication used to treat opioid use disorder and dependence. As medication-assisted treatment (MAT), methadone helps prevent opioid withdrawal and reduces drug cravings by activating opioid receptors in the brain similarly to other opioid drugs. However, it does not produce the same level of euphoria or sedation, allowing those in treatment to function more normally.
- Methadone is taken orally once daily in supervised opioid treatment programs (OTPs).
- Societal perspectives on methadone treatment are mixed. While it helps stabilize individuals and reduce illegal opioid use and associated crime, some view it as merely replacing one addiction with another. However, research shows methadone significantly improves outcomes when properly regulated.
Methadone Distribution
Methadone distribution is strictly monitored with several regulations:
- Urine testing: Patients must undergo at least eight random drug tests in the first year to ensure compliance and prevent diversion.
- Take-home requirements: For the first 14 days, methadone is only dispensed as a single, daily dose. Over time, additional take-home doses may be allowed for stable patients.
- Interprofessional monitoring: OTPs should have teams of nurses, counselors, social workers, and doctors to coordinate care.
- Prescription drug monitoring: Clinicians should review state PDMP data to ensure safe methadone dosage and prevent dangerous drug interactions.
In Minnesota, methadone is a Schedule II controlled substance, indicating accepted medical use but also potential for abuse. Federal and state laws regulate its distribution through certified OTPs.
Methadone Treatment Effectiveness Research
Methadone has been used to treat opioid addiction since 1947.
Studies demonstrate methadone is an extremely effective MAT option:
- Compared to no medication, those on methadone have 33% fewer opioid-positive drug tests and are 4.44 times more likely to stay in treatment.
- Retention in treatment greatly reduces risks of overdose, disease transmission, and criminal behavior while increasing employment opportunities.
However, methadone does carry risks requiring careful oversight.
- Potential drawbacks include misuse/diversion, severe withdrawal if stopped suddenly
- QTc prolongation and cardiac issues, respiratory depression and overdose when combined with other substances like benzodiazepines.
Still, research suggests methadone is equally as effective as buprenorphine, another MAT option.
So while methadone has risks requiring management, the benefits make it a valuable treatment.
About Center City
Center City is located in Chisago County in east-central Minnesota, United States. It is surrounded by the states of:
The capital and largest city in Minnesota is Minneapolis. Center City covers an area of 1.42 square miles.
Population Statistics
The population of Center City is approximately 871 people.
Demographics:
Gender:
- Male: 50.3%
- Female: 49.7%
Age brackets:
- Under 18 years: 26.5%
- 18 to 64 years: 55.1%
- 65 years and over: 18.4%
The most common occupations in Center City include:
- Management, business, science, and arts: 32.8%
- Sales and office: 24.2%
- Service: 18.9%
- Production, transportation, and material moving: 13.4%
- Natural resources, construction, and maintenance: 10.6%
